Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Ryoji Yasumoto"'
Autor:
Shozo Sugita, Tomoaki Tanaka, Kouichiro Tashiro, Naomasa Yoshida, Akinori Minami, Ryoji Yasumoto, Yasuo Yamakoshi, Tatsuya Nakatani, Akira Tohda
Publikováno v:
Future Science OA
Aim: To investigate whether urine levels of miRNAs that regulate the function of endothelial cells are associated with effectiveness in benign prostatic hyperplasia (BPH) patients treated with a phosphodiesterase type 5 inhibitor, tadalafil. Patients
Autor:
Masato Kamizuru, Kazunobu Sugimura, Ryoji Yasumoto, Seiji Wada, Keisuke Yamamoto, Shinichi Ikemoto, Taketoshi Kishimoto
Publikováno v:
Clinical and Experimental Nephrology. 4:215-219
Background. Growth factors such as insulin-like growth factor, epidermal growth factor, and hepatocyte growth factor have been reported to be effective in the treatment of acute renal failure, but their effectiveness in chronic renal failure has not
Autor:
Gabriel P. Haas, Ryoji Yasumoto, Nobuyasu Nishisaka, Gilda G. Hillman, Ching Y. Wang, Yoshihisa Kinoshita, Richard F. Jones, Philo Morse, Atul Maini, Taketoshi Kishimoto
Publikováno v:
Journal of Immunotherapy. 22:308-314
We investigated the combination therapy of local radiation of lung metastasis and vaccination with autologous tumor cells that produced interleukin (IL)-2, interferon-gamma (IFN-gamma), and granulocyte-macrophage colony-stimulating factor (GM-CSF) us
Autor:
Taketoshi Kishimoto, Seiji Wada, Keisuke Yamamoto, Tatsuya Nakatani, Kawano M, Kazunobu Sugimura, Ryoji Yasumoto, Shinichi Ikemoto, Nobuyasu Nishisaka, Tsujino T, Horii A
Publikováno v:
The Japanese Journal of Urology. 87:1250-1257
BACKGROUND Sixteen patients with invasive bladder cancer were received neoadjuvant methotrexate, vinblastine, pirarubicin and cisplatin chemotherapy on our planning protocol. METHODS The tumor was evaluated after 1 course of chemotherapy by radiograp
Autor:
Ryoji Yasumoto, Taketoshi Kishimoto, Nobuyasu Nishisaka, Masaaki Tsujita, Hironobu Kawanishi, Tsujino T, Horii A
Publikováno v:
Clinical Therapeutics. 17:82-87
Seventy-nine patients with benign prostatic hyperplasia (BPH) were treated with cernitin pollen extract. Patient ages ranged from 62 to 89 years (mean, 68 years). Mean baseline prostatic volume was 33.2 cm3. Cernitin pollen extract was administered i
Publikováno v:
The Japanese Journal of Urology. 85:512-516
Autourethrography (A-UG), a new method of retrograde urethrography was developed, in which the patient injects the contrast medium by himself under fluoroscopical observation by urologists out side of the room. For clinical study of A-UG, comparative
Autor:
Taketoshi Kishimoto, Asakawa M, Takuo Kano, Kawano M, Nobuyasu Nishisaka, Tsujino T, T Sakakura, Kiyo Shindow, Ryoji Yasumoto
Publikováno v:
THE JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE. 15:309-312
Autor:
Masanobu Maekawa, Nobuyasu Nishisaka, Yoshihara H, Ryoji Yasumoto, Taketoshi Kishimoto, Hidenori Kawashima
Publikováno v:
Journal of Japanese Society for Dialysis Therapy. 26:191-194
1990年1月1日から12月31日の1年間に大阪府下で維持透析を受けた慢性腎不全患者を対象に後天性多嚢胞化萎縮腎 (acquired cystic disease of the kidney, ACDK) の発生率ならびに腎癌併発件数に関する調
Autor:
Nobuyasu Nishisaka, Ontaku Fu, Seiji Wada, Shozo Yodoi, Kawano M, Takashi Maekawa, Ryoji Yasumoto, Yoshihara H, Taketoshi Kishimoto
Publikováno v:
Journal of Japanese Society for Dialysis Therapy. 26:1543-1547
Autor:
Nobuyasu Nishisaka, Hidetaka Yoshihara, Tatsuya Nakatani, Kazunobu Sugimura, Takashi Maekawa, Masazumi Asakawa, Ryoji Yasumoto, Masaru Umeda, Wataru Sakamoto, Junji Kawakita, Akinori Horii, Hayahara Nobuyuki, Yoji Morikawa, Shoichi Nishio, Noboru Kashihara, Takaaki Nishijima, Toshikado Sugimoto, Masaaki Tsujita, Masaaki Senju, Kazuyoshi Ezaki, Masaki Kawamura, Hiroshi Tanaka, Yoshiteru Iritai, Hitoshi Kobayakawa, Seiji Wada, Keisuke Yamamoto, Taketoshi Kishimoto
Publikováno v:
The Japanese Journal of Urology. 84:1987-1993
A clinical study was conducted to evaluate the efficacy of combination therapy with interferon (IFN) alpha and gamma in 16 patients with advanced renal cell carcinoma whom we observed between August 1986 and June 1992. Eight patients had already had